The Scientist

» recombination and immunology

Most Recent

image: Llamas as Lab Rats

Llamas as Lab Rats

By | May 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

0 Comments

image: Looking for Latent HIV

Looking for Latent HIV

By | May 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

0 Comments

image: Soluble Signal

Soluble Signal

By | May 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

0 Comments

image: Defeating the Virus

Defeating the Virus

By | May 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

0 Comments

image: Protein Spurs T-Cell Proliferation

Protein Spurs T-Cell Proliferation

By | April 17, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

1 Comment

image: Studying Ebola Survivors

Studying Ebola Survivors

By | April 6, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

1 Comment

image: Cancer Immunotherapist

Cancer Immunotherapist

By | April 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

0 Comments

image: Manipulative Microbiomes

Manipulative Microbiomes

By | April 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

3 Comments

image: Yvonne Saenger: Immunotherapy Pioneer

Yvonne Saenger: Immunotherapy Pioneer

By | April 1, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

5 Comments

image: T Cells of the Skin

T Cells of the Skin

By | March 18, 2015

From diagnostics to vaccines, llama antibodies point to new directions in HIV research.

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech